Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05934149 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lupus Landmark Study: A Prospective Registry and Biorepository

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 21 to 25v10
  2. Study sites: 20 to 21v9
  3. Primary and study completion dates: Dec 2033 to Dec 2035
    • Study sites: 18 to 20
    v8
  4. Study sites: 10 to 18v7
  5. Study sites: 9 to 10v6
Show 4 earlier versionsHide 4 earlier versions
  1. Study sites: 6 to 9v5
  2. Site details revised at 2 of 6 sitesv4
  3. Study sites: 5 to 6v3
  4. Study sites: 2 to 5v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
Trial Details
NCT Number NCT05934149
Lead Sponsor Lupus Research Alliance
Conditions
(from sponsor)		 Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Neuropsychiatric Systemic Lupus Erythematosus
Related terms Lupus Erythematosus, Systemic, Lupus Nephritis, Lupus Vasculitis, Central Nervous System
Enrollment 3,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov